Detalhe da pesquisa
1.
Selective inhibition of TGFß1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.
Sci Transl Med
; 12(536)2020 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32213632